건강보험 청구자료를 이용한 전립선염 환자의 의료 이용 및 항생제 처방 현황
Medical Utilization and Antibiotics Use of Prostatitis Patients in Korea
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Prostatitis, one of the most common diseases of the prostate, is a complex disease with various clinical features. Thisstudy aims to analyze the utilization and prescribing patterns of antibiotics in Korean patients with prostatitis between 2008 and2015. Methods: We used the National Health Insurance Database complied from the Health Insurance Review and AssessmentService (HIRA). The outcomes included the number of claims, number of patients, medical cost, and length of stay for each year. In addition, the prescribing patterns of antibiotics, including fluoroquinolone, and low-dose use of ciprofloxacin and levofloxacinwere investigated. Results: The total number of patients and medical cost increased by 9.5% and 51.7% from 2008 to 2015,respectively. Most prostatitis patients were classified as chronic prostatitis patients. The prescribing proportion of antibiotics forchronic prostatitis outpatients decreased from 71.0% to 66.9% from 2008 to 2015, and fluoroquinolone accounted for more than halfof the total antibiotics. Over 80% of prescription of levofloxacin and ciprofloxacin was identified to be for low-dose use. Conclusion:Most of the patients with prostatitis experienced pain relief and condition improvement after antibiotic treatment; however, chronicprostatitis and chronic pelvic pain syndrome recur easily. Therefore, active disease management and further studies are needed toenhance our understanding of effective treatment for prostatitis.
Abstract
Background: Prostatitis, one of the most common diseases of the prostate, is a complex disease with various clinical features. Thisstudy aims to analyze the utilization and prescribing patterns of antibiotics in Korean patients with prostatitis between 2008 and2015. Methods: We used the National Health Insurance Database complied from the Health Insurance Review and AssessmentService (HIRA). The outcomes included the number of claims, number of patients, medical cost, and length of stay for each year. In addition, the prescribing patterns of antibiotics, including fluoroquinolone, and low-dose use of ciprofloxacin and levofloxacinwere investigated. Results: The total number of patients and medical cost increased by 9.5% and 51.7% from 2008 to 2015,respectively. Most prostatitis patients were classified as chronic prostatitis patients. The prescribing proportion of antibiotics forchronic prostatitis outpatients decreased from 71.0% to 66.9% from 2008 to 2015, and fluoroquinolone accounted for more than halfof the total antibiotics. Over 80% of prescription of levofloxacin and ciprofloxacin was identified to be for low-dose use. Conclusion:Most of the patients with prostatitis experienced pain relief and condition improvement after antibiotic treatment; however, chronicprostatitis and chronic pelvic pain syndrome recur easily. Therefore, active disease management and further studies are needed toenhance our understanding of effective treatment for prostatitis.
참고문헌 (31)
- 정홍, "만성전립선염의 유발 및 악화 인자", Urogenital Tract Infection, 8(1), pp.7~12 (2013), 대한요로생식기감염학회
- 김규식, "만성 전립선염", 만성 골반통증 증후군 치료법의 최신 경향, 2014, pp.12(1), 23~28[DOI]
- "Korean Urological Association"[URL]
- Krieger JN, "Epidemiology of prostatitis", Int J Antimicrob Agents, 31(Suppl 1), pp.S85~S90 (2008)
- Mehik A, "Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study", BJU Int, 86, pp.443~448 (2000)[DOI]
- Collins MM, "Prevalence and correlates of prostatitis in the health professionals follow-up study cohort", J Urol, 167(3), pp.1363~1366 (2002)[DOI]
- Krieger JN, "NIH consensus definition and classification of prostatitis", JAMA, 282, pp.236~237 (1999)[DOI]
- 조인래, "전립선염의 현재와 미래", Investigative and Clinical Urology, 49(6), pp.475~489 (2008), 대한비뇨의학회
- Nickel JC, "Prostatitis", Can Urol Assoc J, 5(5), pp.306~315 (2011)
- Nickel JC, "Chronic bacterial prostatitis: an evolving clinical enigma", Urology, 66(1), pp.2~8 (2005)
- 대한감염학회, "요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염", Infection and Chemotherapy, 43(1), pp.1~25 (2011), 대한감염학회
- Johansen TB, "The role of antibiotics in the treatment of chronic prostatitis: a consensus statement", Eur Urol, 34(6), pp.457~466 (1998)[DOI]
- Tillotson GS, "Quinolones: structure-activity relationships and future predictions", J Med Microbiol, 44(5), pp.320~324 (1996)[DOI]
- North DS, "Levofloxacin, a second-generation fluoroquinolone", Pharmacotherapy, 18(5), pp.915~935 (1998)
- Tugcu V, "A placebo-controlled comparison of the efficiency of triple-and monotherapy in category III B chronic pelvic pain syndrome (CPPS)", Eur Urol, 51(4), pp.1113~1118 (2007)[DOI]
- Nickel JC, "Phenotypic approach to the management of the chronic prostatitis", chronic pelvic pain syndrome, 2010, pp.106(9), 1252~1263
- Anothaisintawee T, "Management of chronic prostatitis", chronic pelvic pain syndrome: a systematic review and network meta-analysis, 2011, pp.305(1), 78~86
- Shoskes DA, "Classification and treatment of men with chronic prostatitis", chronic pelvic pain syndrome using the UPOINT system, 2013, pp.31, 755~760
- Perletti G, "Antimicrobial therapy for chronic bacterial prostatitis", Cochrane Database Syst Rev, 8 (2013)
- "Guidelines for ATC classification and DDD assignment 2016"[URL]
- Collins MM, "Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network", J Gen Intern Med, 16(10), pp.656~662 (2001)[DOI]
- "National Health Insurance Service"[URL]
- Cho IR, "Chronic Prostatitis", Chronic Pelvic Pain Syndrome: Guidelines for Antibiotic Therapy, 2006, pp.1(1), 39~44
- "Health Insurance Review and Assessment Service"[URL]
- "Ministry of Health and Welfare"[URL]
- Sharp VJ, "Prostatitis: diagnosis and treatment", Am Fam Physician, 82(4), pp.397~406 (2010)
- Snow DC, "Pharmacotherapy of prostatitis", Expert Opin Pharmacother, 11(14), pp.2319~2330 (2010)[DOI]
- Rees J, "Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis", chronic pelvic pain syndrome: a consensus guideline, 2015, pp.116(4), 509~525
- "Prostatitis;Canadian guidelines on sexually transmitted infections Section 4 - Management and Treatment of Specific Syndromes"[URL]
- Dickson G, "Prostatitis: diagnosis and treatment", Aust Fam Physician, 42(4), pp.216~ (2013)
- 김홍국, "향후 치료를 위한 Chronic Prostatitis", Chronic Pelvic Pain Syndrome 환자들의 증상분석, 2006, pp.10(1), 49~54[DOI]